BEBTELOVIMAB vs BELANTAMAB MAFODOTIN-BLMF: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
BEBTELOVIMAB vs BELANTAMAB MAFODOTIN-BLMF: Safety Overview
| Metric | BEBTELOVIMAB | BELANTAMAB MAFODOTIN-BLMF |
|---|---|---|
| Total FAERS Reports | 1,383 | 150 |
| Deaths Reported | 20 | 60 |
| Death Rate | 1.4% | 40.0% |
| Hospitalizations | 224 | 36 |
| Average Patient Age | 56.4 yrs | 65.9 yrs |
| % Female Patients | 66.9% | 48.3% |
| Marketing Status | N/A | Prescription |